Primary sclerosing cholangitis - a comprehensive review.

Area of Science:

• Hepatology and Gastroenterology
• Autoimmune Liver Diseases
• Bile Duct Disorders

Background:

• Primary sclerosing cholangitis (PSC) is a rare, chronic liver disease characterized by multifocal bile duct strictures.
• It is strongly associated with inflammatory bowel disease (IBD) and carries a high risk of cholangiocarcinoma and colorectal cancer.
• Current management options are limited, and liver transplantation is often required, with a risk of disease recurrence post-transplant.

Purpose of the Study:

• To provide a comprehensive review of the current status of primary sclerosing cholangitis research and clinical practice.
• To highlight recent advancements in understanding PSC pathogenesis and disease behavior.
• To discuss practical, patient-centered management strategies and emerging therapeutic developments.

Main Methods:

• Literature review and synthesis of recent research findings.
• Analysis of clinical data related to patient stratification and disease progression.
• Overview of current and investigational therapeutic approaches.

Main Results:

• Significant progress has been made in understanding the underlying mechanisms of PSC.
• New insights into patient stratification and disease behavior are emerging.
• Ongoing research focuses on developing targeted therapies based on pathogenic pathways.

Conclusions:

• Primary sclerosing cholangitis remains a challenging disease with substantial unmet patient needs.
• Advances in understanding pathogenesis are paving the way for novel therapeutic interventions.
• A multidisciplinary, patient-centered approach is crucial for managing PSC and its complications.